of the
population living and working near oil extraction sites. Based on the results obtained, we evaluated
Erdman, V.V.,
Nasibullin, T.R.,
Tuktarova, I.A.,
Timasheva, Y.R.,
Danilko, K.V.,
Viktorova, T.V.,
Mustafina, O.E. (2020) populations of 2511 residents of the Republic of Bashkortostan—Russians, Bashkirs, and Tatars. We investigated
GAREEV, I.,
YANG, G.,
SUN, J.,
BEYLERLI, O.,
CHEN, X.,
ZHANG, D.,
ZHAO, B.,
ZHANG, R.,
SUN, Z.,
YANG, Q.,
LI, L.,
ZHAO, S.,
PAVLOV, V.,
SAFIN, S. (2020) biomarkers for the diagnosis of ICH. Methods: The plasma
samples from 106 patients with ICH and 50 patients
YANG, G.,
SUN, J.,
SHI, H.,
ZHAO, S.,
GAREEV, I.,
BEYLERLI, O.,
PAVLOV, V.,
IZMAILOV, A. (2020) for processing
samples, methods of analysis, and especially strategies for standardizing results. Moreover, mi
GILYAZOVA, I.R.,
KLIMENTOVA, E.A.,
BERMISHEVA, M.A.,
KHUSNUTDINOVA, E.K.,
IZMAILOV, A.A.,
GALIMOVA, E.F.,
SAFIULLIN, R.I.,
GALIMOV, S.N.,
V.N. Pavlov,
BULYGIN, K.V. (2020) was performed on 23 paired DNA
samples extracted from kidney tumour tissue and the surrounding normal renal
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) .84; 95% CI (1.03–3.31)). Undoubtedly, further study of miRNAs on large groups of
samples is necessary
Larionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) be measured in patients’
samples (tumor tissue and blood). CD68 is the major biomarker for the quantification